The Oregon Bioscience Incubator (OBI) and OTRADI (Oregon Translational Research and Development Institute) are nonprofit innovation, incubator, and commercialization support organizations based in Portland, Oregon, USA focused on advancing bioscience research into viable startups and products — not a traditional VC or accelerator that directly invests capital for equity. 

Specific Funding Stage
Pre-Seed / Early Stage Support: OTRADI/OBI primarily assist early-stage bioscience startups with infrastructure, lab space, entrepreneurial mentoring, product development expertise, and commercialization support rather than acting as an institutional investor.
Seed / Early Institutional: OBI client companies often go on to raise external venture rounds (e.g., private VC or angel funding) after incubation, but OTRADI/OBI itself typically does not function as a direct lead investor in those rounds. 

Investment Amount and Percentage Equity (Company-Level)
• Equity Taken: OTRADI/OBI do not take equity in companies simply for participation in the incubator or use of its services. Their core mission is to provide infrastructure, mentoring, and commercialization acceleration, not to deploy direct capital in exchange for company ownership as a VC would.
• If a startup receives an equity investment, that typically comes from external investors (e.g., private angel groups, VC firms) through programs such as Angel Oregon Life & Bioscience (AOBIO) — where equity deals are negotiated directly between founders and investors, independent of OTRADI’s incubator role.
• Examples show companies associated with OBI have later raised meaningful funding (e.g., seed and VC rounds), but those investment terms/ownership percentages are set between founders and outside investors, not by the incubator itself. 

Equity Structure:
• OTRADI/OBI do not publish or impose a standard ownership percentage for startups. Any ownership dilution seen by incubated companies occurs when they raise money from third-party investors (e.g., angel funds participating in Angel Oregon cohorts), not due to policy of the incubator. 

Application / Submission Method
Submission Method: Startups typically engage with the incubator by becoming an OBI resident or client — applying for lab/office space and access to mentoring and commercialization programs.
Incubator Intake: Prospective bioscience companies submit applications demonstrating research progress and a need for wet lab access, technical support, or business mentoring. 

Sector Focus: Life sciences and bioscience sectors (including therapeutics, diagnostics, medical devices, digital health, etc.).
 Geography: Primarily Oregon-based or affiliated bioscience startups, though collaborations and consortium connections may include broader Pacific Northwest partners.
Stage: Pre-seed to early growth; often pre-venture companies needing lab space, mentoring, and proof-of-concept support. 
Team: Founders and scientists forming ventures from academic research or early commercial activity.

Initial Intake: Evaluation of startup’s bioscience project and fit with OBI’s lab space and incubation capacity.
 Mentorship & Support: Resident companies receive entrepreneurial mentoring, technical expertise, and community access to help refine commercialization strategy.
Investor Readiness: OBI often collaborates with regional ecosystems (e.g., Angel Oregon Life & Bioscience) to help companies prepare for external equity investment. 

Strategic Support: Access to state-of-the-art bioscience lab facilities, shared equipment, and technical expertise — critical for wet lab startups that cannot otherwise afford infrastructure.
Commercialization Mentorship: Dedicated mentor programs, including business strategy, investor readiness, and market development coaching.
Community & Networking: Connections to regional investors, alma ecosystem partners, and programs like AOBIO, increasing exposure to potential capital. 
Operational Support: Business formation guidance, regulatory navigation, and commercialization planning.